A Different Approach to the EGFR Inhibitor Gefitinib Involving Solid-Phase Synthesis

Synlett - Germany
doi 10.1055/s-0037-1610127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

A Solid-Phase Approach for the Synthesis of Α-Aminoboronic Acid Peptides

RSC Advances
ChemistryChemical Engineering
2018English

P1.01-20 Phase III Study Comparing Gefitinib (G) to Gefitinib Combined With Carboplatin and Pemetrexed (GCP) for NSCLC With EGFR Mutations (NEJ009)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Synergistic Antitumour Activity of HDAC Inhibitor SAHA and EGFR Inhibitor Gefitinib in Head and Neck Cancer: A Key Role for ΔNp63α

British Journal of Cancer
Cancer ResearchOncology
2019English

Improvements to Solid Phase Phosphotriester Synthesis of Deoxyoligonucleotides

Nucleic Acids Research
Genetics
1982English

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Peptide and Protein Synthesis by Solid-Phase Synthesis and Segment Condensation Approach With Oxime Resin.

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry
Organic Chemistry
1994English

Automated Solid Phase Synthesis of Oligoarabinofuranosides

Chemical Communications
SurfacesAlloysMaterials ChemistryCoatingsMetalsOpticalMagnetic MaterialsFilmsCatalysisChemistryElectronicCompositesCeramics
2013English

Shikonin Sensitizes Wild‑type EGFR NSCLC Cells to Erlotinib and Gefitinib Therapy

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

First-Line Gefitinib Bei Nachweis Aktivierender EGFR-Mutationen

Best Practice Onkologie
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy